Serial Number
88225561
Owner
PEBBLE LABS INC.Attorney
David S. KerrFirst Use Date
Dec 4, 2018
Filing Date
Dec 11, 2018
MERMAID BIO Trademark
Serial Number: 88225561 • Registration: 5819333
Trademark Classes
Owner Contact Info
Legal Representation
Correspondence Address
DAVID S. KERR BERG HILL GREENLEAF RUSCITTI LLP
1712 PEARL ST.
BOULDER, CO 80302
UNITED STATES
Trademark Details
Filing Date
December 11, 2018
Registration Date
July 30, 2019
First Use Anywhere
December 4, 2018
First Use in Commerce
December 4, 2018
Published for Opposition
May 14, 2019
Cancellation Date
February 13, 2026
Goods & Services
Medical research and development in the field of synthetic biology, molecular biology, genetic engineering and bioinformatics; Research and development biopharmaceutical compounds, namely, RNA-based therapeutic agents to inhibit pathogens directed to aquatic organism; Research and development biopharmaceutical compounds, namely, RNA-based therapeutic agents to inhibit pathogens directed to aquatic organism grown in aquaculture; Research and development of biopharmaceutical compounds, namely, RNA-based therapeutic agents to inhibit the expression of target genes in pathogens affecting to aquatic organisms; Research and development of biopharmaceutical compounds, namely, RNA-based therapeutic agents to inhibit the expression of target genes in pathogens affecting to aquatic organisms grown in aquaculture; Research and development of genetically engineered organisms, namely, genetically engineered bacteria that produce RNA-based therapeutic agents to inhibit the expression of target genes in pathogens affecting to aquatic organisms; Research and development of genetically engineered organisms, namely, genetically engineered bacteria that produce RNA-based therapeutic agents to inhibit the expression of target genes in pathogens affecting to aquatic organisms grown in aquaculture; Research and development biopharmaceutical compounds, namely, RNA-based therapeutic agents to inhibit bacterial quorum-sensing Research and development of genetically engineered organisms, namely, genetically engineered bacteria that produce RNA-based therapeutic agents to inhibit bacterial quorum-sensing; Research and development of new biological products for therapeutic use to prevent or treat aquatic diseases; Research and development of new biological products for therapeutic use to prevent or treat diseases affecting animals grown in aquaculture